Evaluation of the evectiveness of topical ciproxoxacin and prednisolone in the prevention of myringosclerosis

European Archives of Oto-Rhino-Laryngology

Volumn 269, Issue 11, 2012, Pages 2335-2341

  Arslan, Necmi ^a   Tepe, Davut ^a   Taotan, Eren ^a   Demirci, Munir ^a   Caydere, MuzaVer ^a   Ustun, Huseyin ^a   Oguz, Haldun ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

CiproXoxacin; Corticosteroid; Myringosclerosis; Rat; Tympanosclerosis

Indexed keywords

CIPROFLOXACIN; NORFLOXACIN; PREDNISOLONE; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EARDRUM; EARDRUM DISEASE; HISTOPATHOLOGY; MALE; MYRINGOSCLEROSIS; MYRINGOTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; TEMPORAL BONE; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; MIDDLE EAR VENTILATION; PATHOLOGY; POSTOPERATIVE COMPLICATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; CIPROFLOXACIN; DISEASE MODELS, ANIMAL; MALE; MIDDLE EAR VENTILATION; MYRINGOSCLEROSIS; POSTOPERATIVE COMPLICATIONS; PREDNISOLONE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84867239684     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-011-1889-z     Document Type: Article

References (28)

1. Forseni M, Hansson GK, Bagger-Sjöback D, Hultcrantz M (1999) An immunhistochemical study of inducible nitric oxide synthase in the rat middle ear, with reference to tympanosclerosis. Acta Otolaryngol 119:577-582
2. Asiri S, Hahsam A, Anazy FA, Zakzouk S, Banjar A (1999) Tympanosclerosis: review of literature and incidence among patients with middle-ear infection. J Laryngol Otol 113:1076-1080
3. Sorensen H, True O (1972) Histology Of Tympanosclerosis. Acta Otolaryngol 73:18-26
4. Selcuk A, Akdogan O, Ozcan I, Giray SG, Dere H, Ozogul C (2008) Topical Application of calcium channels blockers to reduce the progression of experimentally induced myringosclerosis and tympanosclerosis. Laryngoscope 118:697-705
5. Wielinga EWJ, Kerr AG (1993) Tympanosclerosis. Clin Otolaryngol 18:341-349
6. Ozcan C, Gorur K, Cinel L, Talas DU, Unal M, Cinel I (2002) The inhibitory eVect of topical Nacetylcysteine application on myringosclerosis in perforated rat tympanic membrane. Int J Ped Otorhinolaryngol 63:179-184
7. Spratley JE, Hellstrom SO, Mattsson C, Pais-Clemente M (2001) Topical ascorbic acid reduces myringosclerosis in perforated tympanic membranes. A study in rat. Ann Otol Rhinol Laryngol 110:585-591
8. Khan AA, Slifer TR, Araujo FG, Suzuki Y (2000) Remington JS: protection against lipopolysaccharide- induced death by Xuoroquinolones. Antimicrob Agents Chemother 44:3169-3173
9. Mattsson C, Stierna P, Hellström S (2000) Treatment with dexamethasone arrests the development of myringosclerosis after myringotomy. Am J Otol 21:804-808
10. Mattsson C, Marklund SL, Hellström S (1997) Application of oxygen free radical scavengers to diminish the occurrence of myringosclerosis. Ann Otol Rhinnol Laryngol 106:513-518
11. Celik H, Felek SA, Islam A, Safak MA, Arslan N, Gocmen H (2008) Analysis of long-term hearing after tympanosclerosis with total/partial stapedectomy and prosthesis used. Acta Otolaryngol 128:1308-1313
12. Emir H, Kaptan ZK, Samim E, Sungu N, Ceylan K, Ustun H (2009) The preventive eVect of ginkgo biloba extract in myringosclerosis: study in rats. Otolaryngol Head Neck Surg 140(2):171-176
13. Somers T, Houben V, Goovaerts G, Govaerts PJ, OVeciers FE (1997) Histology of the perforated tympanic membrane and its muco-epithelial junction. Clin Otoaryngol Allied Sci 22:162-166
14. Santos PF, Leal MC, Peixoto C, Neto SC, Rosas ST (2005) Otomicroscopic and histologic Wndings of induced myringosclerosis in rats: a critical study of an experimental model. Braz J Otorhinolaryngol 71(5):668-674
15. Mattsson C, Magnuson K, Hellström S (1995) Myringosclerosis caused by increased oxygen concentration in traumatized tympanic membranes: experimental study. Ann Otol Rhinol Laryngol 104:625-632
16. Polat S, Öztürk O, Üneri C, Yüksel M, Haklar G, Bozkurt S, Küllü S (2004) Determination of reactive oxygen species in myringotomized tympanic membranes and the eVect of vitamin E treatment. Laryngoscope 114:720-725
17. Görür K (2002) The anti-oxidant and anti-apoptotic activities of selenium in the prevention of myringosclerosis in rats. J Laryngol Otol 116(6):426-429
18. Ozcan I, Selcuk A, Ozcan KM, Akdogan O, Giray SG, Dere H, Ozogul C (2008) The eVect of topical doxycycline in the prevention of experimental tympanosclerosis. Laryngoscope 118(6):1051-1056
19. Cankaya H (2008) EVects of topical mitomycin and trimetazidine on myringosclerosis. J Otolaryngol Head Neck Surg 37(6):882-887
20. Cutler JL, Wall M, Labadie RF (2006) EVects of steroid and NSAID in clearing middle ear eVusion in animal model. Otolaryngol Head Neck Surg 135:4-585
21. Giles W, Dohar J, Inverson K (2007) CiproXoxacin/dexamethasone drops decrease the incidence of phisicihian and patient outcomes of otorrhea after tube placement. Int J of Pediatr Otorhinolaryngol 71:747-749
22. Hebda PA, Yuksel S, Dohar JE (2007) EVects of ciproXoxacindexamethasone on mryngotomi wound healing. Laryngoscope 117:522-526
23. Katsuno G, Takahashi HK, Iwagaki H, Sugita S, Mori S, Saito S, Yoshino T, Nishibori M, Tanaka N (2006) The eVect of ciproXoxacin on CD14 and toll-like receptor-4 expression on human monocytes. Shock 25(3):247-253
24. Tsai WC, Hsu CC, Tang FT, Wong AM, Chen YC, Pang JH (2008) CiproXoxacin-mediated cell proliferation inhibition and G2/M cell cycle arrest in rat tendon cells. Arthritis Rheum 58(6):1657-1663
25. Corps AN, Harrall RL, Curry VA, Fenwick SA, Hazleman BL, Riley GP (2002) CiproXoxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1+ in human tendon- derived cells. A potential mechanism of Xuoroquinolone-induced tendinopathy. Arthritis Rheum 46(11):3034-3040
26. Claes J, Govaerts PJ, Van De Heyning PH, Peeters S (1991) Lack of ciproXoxacin itotoxicity after repeated ototopical application. Antimicrob Agents Chemother 35(5):1014-1016
27. Bourikas LA, Kolios K, Valatas V, Notas G, Drygiannakis I, Pelagiadis I, Manousou P, Klironomos S, Mouzas IA, Kouroumalis E (2009) CiproXoxacin decreases survival in HT-29 cells via the induction of TGF-1 secretion and enhances the anti-proliferative eVect of 5-Xuorouracil. Br J Pharmacol 157:362-370
28. Huddleston PM, Steckelberg JM, Hanssen AD, Rouse MS, Bolander ME, Patel R (2000) CiproXoxacin inhibition of experimental fracture-healing. J Bone Joint Surg Am 82:161-173